Skip to main content
CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
3.790
-0.160 (-4.05%)
Nov 7, 2024, 4:00 PM EST - Market closed

CollPlant Biotechnologies Revenue

CollPlant Biotechnologies had revenue of $249.00K in the quarter ending June 30, 2024, a decrease of -97.55%. This brings the company's revenue in the last twelve months to $689.00K, down -93.61% year-over-year. In the year 2023, CollPlant Biotechnologies had annual revenue of $10.96M with 3,565.22% growth.

Revenue (ttm)
$689.00K
Revenue Growth
-93.61%
P/S Ratio
65.65
Revenue / Employee
$9,187
Employees
75
Market Cap
43.41M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202310.96M10.66M3,565.22%
Dec 31, 2022299.00K-15.34M-98.09%
Dec 31, 202115.64M9.50M154.86%
Dec 31, 20206.14M3.82M164.75%
Dec 31, 20192.32M-2.70M-53.77%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
LakeShore Biopharma 79.42M
Exagen 56.66M
SHL Telemedicine 55.94M
Carisma Therapeutics 20.71M
ProPhase Labs 17.97M
DURECT 8.41M
IceCure Medical 3.34M
Revenue Rankings

CLGN News

More News